Share This
table started by
mikeshwe for the Medicine Commons
There is no user-contributed description yet.
Add More Topics
Save this view to a base, or just for yourself.
116 Survival Rate topics matching:
Filter this Collection
Sort by
Date Added
↓
| yr. | % |
|
|||||
|---|---|---|---|---|---|---|---|
| x Disease Stage | x Years (yr.) | x Rate (%) | x Gender | x Race | |||
| x name | x image | x article | |||||
| Stage IV Bladder Cancer | 5 yr. | 16 % | |||||
| Stage III Bladder Cancer | 5 yr. | 38 % | |||||
| Stage 0 Bladder Cancer | 5 yr. | 95 % |
Stage 0 includes Ta, Tis, N0, M0 Ta: Non-invasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003
|
||||
| Stage II Bladder Cancer | 5 yr. | 55 % |
Stage II includes the following: T2a or T2b + N0, M0. T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003
|
||||
| Stage I Bladder Cancer | 5 yr. | 85 % |
Staging includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.)-2--3
|
||||
| Stage II Breast Cancer | 5 yr. | 86 % |
Stage II includes: IIA: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0) and IIB: (T2, N1, MO); (T3,NO,MO). T0: No evidence of primary tumor. T2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension. T3: Tumor more than 5.0 cm in...
|
||||
| Stage I Breast Cancer | 5 yr. | 100 % | |||||
| Stage 0 Breast Cancer | 5 yr. | 100 % |
Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IV Breast Cancer | 5 yr. | 20 % |
Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th Ed.) - 2003
|
||||
| Stage III Breast Cancer | 5 yr. | 57 % | |||||
| Stage I Colorectal Cancer | 5 yr. | 93 % |
Stage I includes: T1, T2 and NO, MO. T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis (AJCC 6th ed.)-2003
|
||||
| Stage IIB Colorectal Cancer | 5 yr. | 72 % | |||||
| Stage IIA Colorectal Cancer | 5 yr. | 85 % | |||||
| Stage IIIC Colorectal Cancer | 5 yr. | 44 % | |||||
| Stage IV Colorectal Cancer | 5 yr. | 8 % |
Stage IV includes: Any T, any N, M1. M1: Distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IIIB Colorectal Cancer | 5 yr. | 64 % | |||||
| Stage IIIA Colorectal Cancer | 5 yr. | 83 % | |||||
| Stage IA Melanoma | 5 yr. | 99 % | |||||
| Stage IB Melanoma | 5 yr. | 92 % | |||||
| Stage IIC Melanoma | 5 yr. | 56 % | |||||
| Stage IV Melanoma | 5 yr. | 18 % | |||||
| Stage IIA Melanoma | 5 yr. | 78 % | |||||
| Stage IIB Melanoma | 5 yr. | 68 % | |||||
| Stage IIIB Melanoma | 5 yr. | 50 % | |||||
| Stage IIIC Melanoma | 5 yr. | 27 % | |||||
| Stage IV Endometrial Cancer | 5 yr. | 30 % | |||||
| Stage IB Endometrial Cancer | 5 yr. | 99 % | |||||
| Stage IC Endometrial Cancer | 5 yr. | 92 % | |||||
| Stage III Endometrial Cancer | 5 yr. | 60 % | |||||
| Stage IA Endometrial Cancer | 5 yr. | 99 % | |||||
| Stage II Endometrial Cancer | 5 yr. | 80 % | |||||
| 1 yr. | 79 % | ||||||
| 10 yr. | 51 % | ||||||
| 5 yr. | 63 % | ||||||
| Stage IA Ovarian Cancer | 5 yr. | 92.7 % |
Stage IA includes: T1a, N0, M0. T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) ...
|
||||
| Stage IIB Ovarian Cancer | 5 yr. | 72.4 % |
Stage IIB includes: T2b N0, M0. T2b: Extension and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IC Ovarian Cancer | 5 yr. | 84.7 % |
Stage IC includes: T1c, N0, M0. T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No...
|
||||
| Stage IIIC Ovarian Cancer | 5 yr. | 31.5 % |
Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed....
|
||||
| Stage IIIA Ovarian Cancer | 5 yr. | 50.8 % |
Stage IIIA includes: T3a, N0, M0. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IIIB Ovarian Cancer | 5 yr. | 42.4 % |
Stage IIIB includes: T3b, N0, M0. T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IV Ovarian Cancer | 5 yr. | 17.5 % | |||||
| Stage IB Ovarian Cancer | 5 yr. | 85.4 % |
Stage IB includes: T1b, N0, M0. T1b: Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed...
|
||||
| Stage IIA Ovarian Cancer | 5 yr. | 78.6 % |
Stage IIA includes: T2a, N0, M0. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
|
||||
| Stage IIC Ovarian Cancer | 5 yr. | 64.4 % |
Stage IIC includes: T2c N0, M0. Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washing. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant...
|
||||
| Stage IIA Pancreatic Cancer | 5 yr. | 12 % | |||||
| Stage IV Pancreatic Cancer | 5 yr. | 1 % | |||||
| Stage IA Pancreatic Cancer | 5 yr. | 37 % | |||||
| Stage IIB Pancreatic Cancer | 5 yr. | 6 % | |||||
| Stage IB Pancreatic Cancer | 5 yr. | 21 % | |||||
| Stage III Pancreatic Cancer | 5 yr. | 2 % | |||||
| 5 yr. | 46.7 % | ||||||
| 5 yr. | 75 % | ||||||
| 5 yr. | 21 % | ||||||
| 5 yr. | 66.1 % | ||||||
| Regional Stage Prostate Cancer | 5 yr. | 89 % |
A regional stage prostate cancer means the cancer has spread from the prostate to nearby areas.
|
||||
| Distant Stage Prostate Cancer | 5 yr. | 37 % |
Distant stage prostate cancer means that the cancer has spread beyond the prostate to distant lymph nodes, bone, or other organs.
|
||||
| Local Stage Prostate Cancer | 5 yr. | 100 % |
Local stage prostate cancer means that the cancer has not spread outside of the prostate.
|
||||
| Stage III Kidney Cancer | 5 yr. | 30 % | |||||
| Stage III Kidney Cancer | 5 yr. | 55 % | |||||
| Stage I Kidney Cancer | 5 yr. | 90 % | |||||
